Publications by authors named "Simona Colla"

Claim this Profile
C
Clinical and molecular features of immunodeficiency in patients with telomere biology disorders.
Luiz Fernando Bazzo Catto, Nidhi Aggarwal, Ruba Shalhoub, Xiaoyang Ma, Ivana Darden, Simona Colla

Blood· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation.
Hidetaka Uryu, Koichi Saeki, Hiroshi Haeno, Chiraag Deepak Kapadia, Ken Furudate, Simona Colla

Nat Genet· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation.
Hidetaka Uryu, Koichi Saeki, Hiroshi Haeno, Chiraag Deepak Kapadia, Ken Furudate, Simona Colla

Nat Genet· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer cells' functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromes.
Juan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Bijender Kumar, Natthakan Thongon, Feiyang Ma, Simona Colla

Nat Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrative multiparametric approach stratifies putative distinct phenotypes of blast phase chronic myelomonocytic leukemia.
Kristian Gurashi, Yu-Hung Wang, Fabio M R Amaral, Katherine Spence, Rachel Cant, Simona Colla

Cell Rep Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescue and cancer mutations.
Fernanda Gutierrez-Rodrigues, Emma M Groarke, Natthakan Thongon, Juan Jose Rodriguez-Sevilla, Luiz Fernando B Catto, Simona Colla

Blood· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation in myelodysplastic syndrome pathogenesis.
Juan Jose Rodriguez-Sevilla, Simona Colla

Semin Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The IL-1β inhibitor canakinumab in previously treated lower-risk myelodysplastic syndromes: a phase 2 clinical trial.
Juan Jose Rodriguez-Sevilla, Vera Adema, Kelly S Chien, Sanam Loghavi, Feiyang Ma, Simona Colla

Nat Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML.
Bijender Kumar, Anand Singh, Rafet Basar, Nadima Uprety, Ye Li, Simona Colla

Sci Transl Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A STAT3 Degrader Demonstrates Pre-clinical Efficacy in Venetoclax resistant Acute Myeloid Leukemia.
Samarpana Chakraborty, Claudia Morganti, Bianca Rivera Pena, Hui Zhang, Divij Verma, Simona Colla

bioRxiv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemia.
Guillermo Montalban-Bravo, Natthakan Thongon, Juan Jose Rodriguez-Sevilla, Feiyang Ma, Irene Ganan-Gomez, Simona Colla

Cell Rep Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML.
Matteo Marchesini, Andrea Gherli, Elisa Simoncini, Lucas Moron Dalla Tor, Anna Montanaro, Simona Colla

Nat Commun· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT3 protects hematopoietic stem cells by preventing activation of a deleterious autocrine type-I interferon response.
Bhakti Patel, Yifan Zhou, Rachel L Babcock, Feiyang Ma, M Anna Zal, Simona Colla

Leukemia· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal evolution of hematopoietic stem cells after cancer chemotherapy.
Hidetaka Uryu, Koichi Saeki, Hiroshi Haeno, Chiraag Deepak Kapadia, Ken Furudate, Simona Colla

bioRxiv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell dysfunctions in myelodysplastic syndromes.
Juan Jose Rodriguez-Sevilla, Simona Colla

Blood· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral decitabine plus cedazuridine and venetoclax in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: a single-centre, phase 1/2 study.
Alex Bataller, Guillermo Montalban-Bravo, Alexandre Bazinet, Yesid Alvarado, Kelly Chien, Simona Colla

Lancet Haematol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A road map of relapse in MDS after allo-HSCT.
Juan Jose Rodriguez-Sevilla, Simona Colla

Blood· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes.
Juan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Feiyang Ma, Kelly Chien, Monica Del Rey, Simona Colla

Nat Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma.
Natthakan Thongon, Feiyang Ma, Natalia Baran, Pamela Lockyer, Jintan Liu, Simona Colla

Nat Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells.
Yannan Jia, Lina Han, Cassandra L Ramage, Zhe Wang, Connie C Weng, Simona Colla

Haematologica· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-1β-mediated inflammatory signaling drives ineffective erythropoiesis in early-stage myelodysplastic syndromes.
Vera Adema, Irene Ganan-Gomez, Feiyang Ma, Juan Jose Rodriguez-Sevilla, Kelly Chien, Simona Colla

bioRxiv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting MCL1-driven anti-apoptotic pathways to overcome hypomethylating agent resistance in -mutated chronic myelomonocytic leukemia.
Guillermo Montalban-Bravo, Feiyang Ma, Natthakan Thongon, Hui Yang, Irene Ganan- Gomez, Simona Colla

bioRxiv· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging treatments for myelodysplastic syndromes: Biological rationales and clinical translation.
Juan Jose Rodriguez-Sevilla, Vera Adema, Guillermo Garcia-Manero, Simona Colla

Cell Rep Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT3 protects HSCs from intrinsic interferon signaling and loss of long-term blood-forming activity.
Bhakti Patel, Yifan Zhou, Rachel L Babcock, Feiyang Ma, Malgorzata A Zal, Simona Colla

bioRxiv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple Myeloma.
Natthakan Thongon, Feiyang Ma, Pamela Lockyer, Natalia Baran, Jintan Liu, Simona Colla

bioRxiv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis